Abstract:Abstract Chemo/radioresistance markedly impair the efficacy of cancer therapy. Anti-apoptotic Bcl-2 family proteins such as Bcl-xL, Bcl-2 and Mcl-1 are overexpressed in castration-resistant prostate cancer (CRPC) and contribute to prostate tumor initiation, progression and resistance to radiotherapy. A natural BH3-mimetic small molecule inhibitor of Bcl-2, (-)-gossypol, shows promise in ongoing Phase II clinical trials for human prostate cancer. We have recently shown that (-)-gossypol preferentially induces autophagy in CRPC cells that have high levels of Bcl-2 and are resistant to apoptosis, both in vitro and in vivo, but not in androgen-dependent cells with low Bcl-2 and sensitive to apoptosis. We have explored a series of gossypol derivatives and identified two novel BH3-mimetic lead compounds that are more potent than the parental compound in inducing autophagic cell death in CRPC. A novel pan-Bcl-2 inhibitor, apogossypolone (ApoG2), a derivative of (-)-gossypol, has a better binding affinity to Mcl-1 and an improved antitumor activity, and shows promising efficacy on a variety of cancers in vitro and in vivo. Treatment with the ApoG2 prior to radiotherapy enhances cell death via autophagic pathway in cancer cells which have high Mcl-1 and resistant to apoptosis. In addition to abrogating Bcl-2/Mcl-1–Beclin1 interactions, ApoG2 activates the autophagic pathway Atg5-dependently which synergizes with the effect of radiation. We further investigated the precise mechanism governing the influence of ApoG2 on IR-induced cell death. Our data suggest that, ApoG2 pretreatment suppresses IR induced Akt activation and mTOR phosphorylation. In this way, it serves as a potent radiosensitizer to affect autophagic cell death in cancer cells. Administration of ApoG2 prior to IR further delayed tumor growth of castration resistant prostate cancer xenograft model and increased autophagic cell death in vivo. Together, our data demonstrate a novel mode of action of ApoG2 as an enhancer of radiation induced autophagic cell death and provide mechanistic details of its tumor cell killing activities. These new insights into different modes of cell death induced by Mcl-1 inhibitors may facilitate the rational design of clinical trials by selecting patients most likely to benefit from the Mcl-1-targeted molecular therapy. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2260. doi:1538-7445.AM2012-2260

Natural Bcl-2 inhibitor (−)– gossypol induces protective autophagy via reactive oxygen species–high mobility group box 1 pathway in Burkitt lymphoma

Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells

The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-Dependent And Beclin 1-Independent Cytoprotective Autophagy In Cancer Cells

Abstract 5085: Radiosensitization of Castration-Resistant Prostate Cancer Via Modulating Autophagic Cell Death

Natural BH3 Mimetic (-)-gossypol Chemosensitizes Human Prostate Cancer Via Bcl-xL Inhibition Accompanied by Increase of Puma and Noxa

Apogossypolone, a Novel Inhibitor of Antiapoptotic Bcl-2 Family Proteins, Induces Autophagy of PC-3 and LNCaP Prostate Cancer Cells in Vitro

The Novel Bh-3 Mimetic Apogossypolone Induces Beclin-1-And Ros-Mediated Autophagy in Human Hepatocellular Cells

Identification of Gossypol Acetate As an Autophagy Modulator with Potent Anti-tumor Effect Against Cancer Cells

Mechanism of(-)-gossypol down-regulating B lymphocyte stimulator expression in Namalwa cells via autophagy

In Vitro Effects of the BH3 Mimetic, (−)-Gossypol, on Head and Neck Squamous Cell Carcinoma Cells

Gossypol Induces Bax/Bak-Independent Activation of Apoptosis and Cytochrome C Release Via A Conformational Change in Bcl-2

Dual Effects of Gossypol on Human Hepatocellular Carcinoma Via Endoplasmic Reticulum Stress and Autophagy.

Ginkgolide B Inhibits Lung Cancer Cells Promotion Via Beclin-1-dependent Autophagy

Valproic Acid Enhances the Anti-tumor Effect of (-)-gossypol to Burkitt Lymphoma Namalwa Cells.

Molecular Mechanism of Gossypol-Induced Cell Growth Inhibition and Cell Death of HT-29 Human Colon Carcinoma Cells.

(-)-Gossypol Suppresses the Growth of Human Prostate Cancer Xenografts Via Modulating Vegf Signaling-Mediated Angiogenesis

Gossypol induces apoptosis of human pancreatic cancer cells via CHOP/endoplasmic reticulum stress signaling pathway

Abstract 2260: Novel Molecular Therapy Targeting Mcl-1 and Modulating Autophagy in Castration-Resistant Prostate Cancer

Bioinformatics Analysis Of The Signaling Pathways And Genes Of Gossypol Induce Death Of Nasopharyngeal Carcinoma Cells

Gossypol Has Anti-Cancer Effects by Dual Targeting Mdm2 and Vegf in Human Breast Cancer

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity As an Inhibitor of Antiapoptotic Proteins.